Journal of Biomedical Engineering Research (대한의용생체공학회:의공학회지)

The Korean Society of Medical and Biological Engineering (대한의용생체공학회)
권호 표지
DOI QR코드

DOI QR Code

A Study on the Establishment of Essential Medical Device System in Korea based on the Analysis of Essential Medical Device Management Systems in Major Countries

주요국의 필수의료기기 운영제도 분석을 통한 국내 필수의료기기 제도 수립 방안 연구

  • Kwang Yun Yu (Department of Advanced Industry Fusion, Konkuk University ) ;
  • Dong Myung Lee (Department of Advanced Industry Fusion, Konkuk University)
  • 유광윤 (건국대학교 대학원 신산업융합학과) ;
  • 이동명 (건국대학교 신산업융합학과)
  • Received : 2024.11.13
  • Accepted : 2024.12.15
  • Published : 2024.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Global supply chain disruptions, exemplified by the COVID-19 pandemic, have underscored the necessity for a stable supply system for essential medical devices. While South Korea has a well-established management system for essential medicines, there is a lack of a system for medical devices critical to patient care. The high dependence on imported medical devices in South Korea may lead to potential disruptions in supply, which pose substantial social implications. This study conducts a comparative analysis of the advanced systems employed by the United States, the European Union, and Japan, with the aim of proposing the establishment of a management system for essential medical devices in South Korea. Based on this analysis, the study identifies key strategies for the designation and stabilization of the supply of medical devices and suggests directions for enhancing the resilience of the healthcare system and emergency response capabilities. This includes incorporating criteria for designating essential medical devices, implementing preemptive measures, and strengthening supply chain management within South Korea.

Keywords

References

  1. Ministry of Government Legislation, Republic of Korea. Pharmaceutical Affairs Act, Article 2, Paragraph 19; Article 83-3. Available from: https://www.law.go.kr/LSW/eng/engMain.do, accessed on Dec. 11, 2024.
  2. http://www.etnews.com/20240405000237, accessed on Oct. 22, 2024.
  3. Korea Health Industry Development Institute. The 1st Medical Device Industry Survey, Seoul, Korea: KHIDI; 2024.
  4. http://www.dailypharm.com/Users/News/NewsView.html?ID=309883, accessed on Oct. 20, 2024.
  5. Ministry of Food and Drug Safety National Institute of Food and Drug Safety Evaluation. A Study on the Designation and Management of Medical Devices to Report the Discontinuation of Supply, Seoul, Korea: MFDS; 2020.
  6. World Health Organization. Prioritizing medical devices. Geneva: WHO; 2023. Available from: http://www.who.int/activities/prioritizing-medical-devices, accessed on Oct. 24, 2024.
  7. U.S. Department of Health and Human Services. Critical Medical Device List: Summary and Recommendations Report, Washington, D.C.: HHS; 2023.
  8. U.S. Congress. Coronavirus Aid, Relief, and Economic Security Act, Pub. L. No. 116-136, 134 Stat. 281, 2020.
  9. European Parliament and Council. Regulation (EU) 2017/745 on Medical Devices (MDR). Official Journal of the European Union; 2017.
  10. https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/crisis-management_en, accessed on Oct. 6, 2024.
  11. https://www.japaneselawtranslation.go.jp/ja/laws/view/3213, accessed on Dec. 10, 2024.
  12. OECD. Securing Medical Supply Chains in a Post-Pandemic World. OECD Health Policy Studies. Paris: OECD Publishing; 2024.
  13. Ministry of Food and Drug Safety (MFDS), Notice on Production and Import Suspension Reporting for Medical Devices, Korea; 2024.
  14. MFDS, 2024 Designated Medical Devices List for Reporting Discontinuation of Production and Import, Korea; 2024.
  15. MFDS 2023, Research on selective application of reporting on details of supply of medical devices, Korea: MFDS; 2023.
  16. Ministry of Food and Drug Safety. Notification No. 2018-392: Regulations on the Supply of Rare and Urgently Needed Medical Devices. 2019.
  17. http://www.whosaeng.com/155809, accessed on Oct. 19, 2024.
  18. U.S. Congress. Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Public Law 107-188.
  19. Congressional Research Service. The Strategic National Stockpile: Overview and Issues for Congress. Sep. 26, 2023.
  20. Executive Order 14001. Executive Order on a Sustainable Public Health Supply Chain. The White House.
  21. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0123, accessed on Nov. 8, 2024.
  22. https://eur-lex.europa.eu/eli/reg/2022/2371/oj, accessed on Nov. 8, 2024.
  23. https://eur-lex.europa.eu/eli/reg/2022/2372/oj, accessed on Nov. 8, 2024.
  24. https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/crisis-management_en, accessed on Nov. 8, 2024.
  25. https://www.japaneselawtranslation.go.jp/en/laws/view/2199/en, accessed on Nov. 8, 2024.
  26. https://www.preventionweb.net/publication/japan-disaster-countermeasures-basic-act-act-no-223-15-november-1961-revised-june-1997, accessed on Nov. 8, 2024.
  27. https://www.ropesgray.com/en/insights/viewpoints/102jlvg/japans-mhlw-highlights-four-key-themes-in-pharmaceuticals-and-medical-devices-ac, accessed on Nov. 8, 2024.
  28. https://www.fda.gov/news-events/fda-voices/fdas-budget-medical-device-supply-chain-and-shortages-prevention-program, accessed on Nov. 8, 2024.
  29. https://www.fda.gov/medical-devices/medical-device-safety/medical-device-supply-chain-and-shortages, accessed on Nov. 9, 2024.
  30. https://www.fda.gov/medical-devices/medical-device-supply-chain-and-shortages/notify-fda-about-medical-device-supply-issue, accessed onanism Nov. 9, 2024.
  31. https://aspr.hhs.gov/SNS/Pages/CHEMPACK.aspx, accessed on Nov. 8, 2024.
  32. https://www.cf.org/backgrounder/state-us-strategic-stockpiles, accessed on Nov. 8, 2024.
  33. https://ec.europa.eu/tools/eudamed/eudamed, accessed on Nov. 8, 2024.
  34. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization, accessed on Nov. 8, 2024.
  35. ANSM (Agence nationale de securite du medicament et des produits de sante). (n.d.). Strategic stockpiling and management of essential medical devices in emergencies. Retrieved December 7, 2024, from https://ansm.sante.fr/
  36. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Risk assessment and manufacturer obligations for medical device supply chain shortages. Available from: https://www.aemps.gob.es, accessed on Dec. 9, 2024.
  37. United States Government Accountability Office. Defense Production Act: Opportunities Exist to Increase Transparency and Identify Future Actions to Mitigate Medical Supply Chain Issues. Washington, D.C.: GAO; Nov. 19, 2020.
  38. Anon. Building Resilient Health Systems to Advance toward Universal Health in the Americas: Lessons from COVID-19. 2022.
  39. European Commission. RescEU - Strengthening European disaster management.